Pharmacokinetics and oral bioavailability of pentoxyfylline in broiler chickens

Journal of Veterinary Pharmacology and Therapeutics

Volumn 28, Issue 6, 2005, Pages 575-580

  De Boever, Sandra ^a   Baert, K ^a   De Backer, P ^a   Croubels, S ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; PENTOXIFYLLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CHICKEN; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEAN RESIDENCE TIME; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; SINGLE DRUG DOSE; STATISTICAL ANALYSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHICKENS; INJECTIONS, INTRAVENOUS; PENTOXIFYLLINE;

ANIMALIA; GALLUS GALLUS;

EID: 28444478115     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2005.00695.x     Document Type: Article

References (29)

1. Ambrus, J., Stadler, S. & Kulaylat, M. (1995) Hemorrheologic effects of metabolites of pentoxifylline (Trental®). Journal of Medicine, 26, 65-75.
2. Anonymous (2000) Veterinary medicinal products: establishment of maximum residue limits (MRLs) for residues of veterinary products in foodstuffs of animal origin: development and validation of a proposed regulatory method. EMEA/CVMP/573/00-FINAL, Notice to applicants, Extract of Volume 8.
3. Anonymous (2002) Commission Decision of 2002/657/EC implementing Council Directive 96/23/EC implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Official Journal of the European Communities, 17/08/2002, No. L221/8-36.
4. Baert, K., Duchateau, L., De Boever, S., Cherlet, M. & De Backer, P. (2005a) Antipyretic effect of oral sodium salicylate after an intravenous E. coli LPS injection in broiler chickens. British Poultry Science, 46, 137-143.
5. Baert, K., De Boever, S., Duchateau, L. & De Backer, P. (2005b) Sodium salicylate attenuates LPS-induced adipsia, but not hypophagia, in broiler chickens. British Poultry Science, 46, 144-148.
6. Beermann, B., Ings, R., Månsby, J., Chamberlain, J. & McDonald, A. (1985) Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clinical Pharmacology and Therapeutics, 37, 25-28.
7. Cesarone, M.R., Belcaro, G., Nicolaides, A.N. et al. (2002) Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomised trial. Angiology, 53, s1-s5.
8. Crisman, M.V., Wilcke, J.R., Correll, L.S. & Irby, M.H. (1993) Pharmacokinetic disposition of intravenous and oral pentoxifylline. Journal of Veterinary Pharmacology and Therapeutics, 16, 23-31.
9. Dawson, D.L., DeMaioribus, C.A., Hagino, R.T., Light, J.T., Bradley, D.V., Britt, K.E. & Charles, B.E. (1999) The effect of withdrawal of drugs treating intermittent claudication. The American Journal of Surgery, 178, 141-146.
10. Goldbach, J., Roth, J., Störr, B. & Zeisberger, E. (1997) Influence of pentoxifylline on fevers induced by bacterial lipopolysaccharide and tumor necrosis factor (TNF)-α in guinea pigs. European Journal of Pharmacology, 319, 273-278.
11. Heitzman, R. (1994) Veterinary Drug Residues, Report Eur 15127-EN. Commission of the EC, Brussels-Luxembourg.
12. Hsu, H.Y., Saadati, H.G., Mishra, A., Heller, K.B. & Sadun, A.A. (2000) Plasma levels of orally and subcutaneously administered pentoxifylline in rabbits. Journal of Medicine, 31, 149-166.
13. Jakobsen, P.H., Koch, C. & Bendtzen, K. (1997) Inhibition of LPS and Plasmodium falciparum induced cytokine secretion by pentoxifylline and two analogues. Scandinavian Journal of Immunology, 45, 546-550.
14. Jacoby, D. & Mohler, E.R., III (2004) Drug treatment of intermittent claudication. Drugs, 64, 1657-1670.
15. Jilg, S., Barsig, J., Leist, M., Küsters, S., Volk, H. & Wendel, A. (1996) Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock. Journal of Pharmacology and Experimental Therapeutics, 278, 421-431.
16. Knecht, J. & Storck, G. (1974) Percentage and logarithmic procedures for calculation of calibration curves. Fresenius Zeitschrift für Analytische Chemie, 270, 97-99.
17. Lambert, W.E., Yousouf, M.A., Van Liedekerke, B.M., De Roose, J.E. & De Leenheer, A.P. (1989) Simultaneous determination of pentoxyfylline and three metabolites in biological fluids by liquid chromatography. Clinical Chemistry, 35, 298-301.
18. Lefebvre D'Hellencourt, C.L., Diaw, L., Cornillet, P. & Guenounou, M. (1996) Differential regulation of TNFα, IL-1β, IL-6, IL-8, TNFβ, and IL-10 by pentoxifylline. International Journal of Immunopharmacology, 18, 739-748.
19. LeMay, L.G., Vander, A.J. & Kluger, M.J. (1990) The effects of pentoxifylline on lipopolysaccharide (LPS) fever, plasma interleukin 6 (IL 6), and tumor necrosis factor (TNF) in the rat. Cytokine, 4, 300-306.
20. Marsella, R., Nicklin, C.F., Munson, J.W. & Roberts, S.M. (2000) Pharmacokinetics of pentoxifylline in dogs after oral and intravenous administration. American Journal of Veterinary Research, 6, 631-637.
21. Miller, K., Louie, A., Baltch, A.L., Smith, R.P., Davis, P.J. & Gordon, M.A. (1998) Pharmacokinetics of pentoxifylline and its metabolites in healthy mice and in mice infected with Candida albicans. Antimicrobial Agents and Chemotherapy, 42, 2405-2409.
22. Nicklasson, M., Björkman, S., Roth, B., Jönsson, M. & Höglund, P. (2002) Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans. Chirality, 14, 643-652.
23. Porter, M.H., Hrupka, B.J., Altreuter, G., Arnold, M. & Langhans, W. (2000) Inhibition of TNF-α production contributes to the attenuation of LPS-induced hypophagia by pentoxifylline. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 279, R2113-R2120.
24. Raju, P.I., Tolman, K.C. Davis, P.J., Ludden, T.M., Roy, T.K. & Johnson, F.E. (1993) Distribution and metabolism of pentoxifylline in non-tumor-bearing mice. Journal of Medicine, 24, 353-368.
25. Rees, C.A., Boothe, D.M., Boeckh, A., Wilkie, S., Esparza, T. & Green, R. (2003) Dosing regimen and hematologic effects of pentoxyfylline and its active metabolites in normal dogs. Veterinary Therapeutics, 4, 188-196.
26. Rocci, M.L., Luke, D.R. & Saccar, C.L. (1987) Pharmacokinetics of pentoxifylline during concomitant theophylline administration in rats. Pharmaceutical Research, 4, 433-435.
27. Smith, R.V., Waller, E.S., Doluisio, J.T., Bauza, M.T., Puri, S.K., Ho, I. & Lassman, H.B. (1986) Pharmacokinetics of orally administered pentoxifylline in humans. Journal of Pharmaceutical Sciences, 75, 47-52.
28. Ward, A. & Clissold, S.P. (1987) Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs, 34, 50-97.
29. Wong, J.W., Yuen, K.H. & Peh, K.K. (1998) Simple high-performance liquid chromatographic method for determination of pentoxifylline in human plasma. Journal of Chromatography B, 716, 387-391.